Showing results (2081-2090 of 2,109) with videos related to
Sort By:
Pageof 211
Advances in Nutrition (Bethesda, Md.)|April 19, 2026
Prognostic nutritional index and cancer prognostic outcomes: an umbrella review of systematic reviews and meta-analyses of observational studiesZhi-Tong Li, Ming-Li Sun, Fang-Hua Liu, et al.Elife|February 9, 2017
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerabilityBrenton R Paolella, William J Gibson, Laura M Urbanski, et al.JTO Clinical and Research Reports|January 3, 2022
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN StudyXue-Ning Yang, Hong-Hong Yan, Jun Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 7, 2018
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)Song-Tao Xu, Jun-Jie Xi, Wen-Zhao Zhong, et al.Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|November 2, 2005
[A field trial for evaluating the safety of recombinant human interferon alpha-2b for nasal spray]Qing Chen, Li-lan Zhang, De-xian Yu, et al.Lung Cancer (Amsterdam, Netherlands)|November 13, 2020
Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II-IIIA (N1-N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) studyJian Zeng, Wei-Min Mao, Qi-Xun Chen, et al.Nature|October 12, 2017
Establishment of mouse expanded potential stem cellsJian Yang, David J Ryan, Wei Wang, et al.Nature|December 18, 2024
Lithocholic acid binds TULP3 to activate sirtuins and AMPK to slow down ageingQi Qu, Yan Chen, Yu Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2020
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III TrialWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.Nature|February 24, 2022
Low-dose metformin targets the lysosomal AMPK pathway through PEN2Teng Ma, Xiao Tian, Baoding Zhang, et al.Pageof 211